Restylane-L
FDA premarket approval P040024/S106 · decided 2019-06-06
Approval details
- PMA number
- P040024
- Supplement
- S106
- Supplement type
- Normal 180 Day Track
- Supplement reason
- Labeling Change - Indications/instructions/shelf life/tradename
- Trade name
- Restylane-L
- Generic name
- Implant, dermal, for aesthetic use
- Applicant
- Q-Med AB
- Date received
- 2018-12-06
- Decision date
- 2019-06-06
- Days to decision
- 182 days
- Decision code
- APPR
- Product code
- LMH
- Advisory committee
- General, Plastic Surgery
- Expedited review
- No
- Location
- Uppsala
- Statement
- Approval for revisions to the clinician and patient labeling of Restylane-L to include updated safety information based on post marketing surveillance data.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.